Potentially serious side effects of high-dose twice-weekly rifampicin - Wikidata - awgldk - TriplyDB

Potentially serious side effects of high-dose twice-weekly rifampicin

Potentially serious side effects of high-dose twice-weekly rifampicin

http://www.wikidata.org/entity/Q28365150

about

Daily dosing of rifapentine cures tuberculosis in three months or less in the murine model Infectious diseases: annual review of significant publications.Hepatorenal failure with self-initiated intermittent rifampicin therapy Myopathy induced by rifampicin Thrombotic thrombocytopenic purpura due to rifampicin.Thrombocytopenia due to rifampicin Do not miss rifampicin-induced thrombocytopenic purpura A case of thrombocytopenia caused by rifampicin and pyrazinamide Rifampin Cutaneous leukocytoclastic vasculitis due to anti-tuberculosis medications, rifampin and pyrazinamide.Adverse reactions to first-line antituberculosis drugs.Safety of rifampin and pyrazinamide for the treatment of latent tuberculosis infection.Assay of rifampicin in serum.Why Do We Use 600 mg of Rifampicin in Tuberculosis Treatment?Current management options for latent tuberculosis: a review.Implication of rifampicin-quinone in the irreversible binding of rifampicin to macromolecules.A dose-ranging trial to optimize the dose of rifampin in the treatment of tuberculosis.New drug regimens in the treatment of tuberculosis.Pharmacokinetics and pharmacogenetics of anti-tubercular drugs: a tool for treatment optimization?Acute renal failure and rifampicin: danger of unsuspected intermittent dosage.Massive haemolysis caused by rifampicin.Rifampicin for lepromatous leprosy: nine years' experience.Tuberculosis--chemotherapy.Sensitivity to rifampicin: incidence, mechanism, and prevention.Rifampicin in Nontuberculous Mycobacterial Infections: Acute Kidney Injury with Hemoglobin Casts.

P2860

Q21144660-89EAF37A-9D03-4677-B298-9E81B0789C4B Q27486591-49407D60-AE51-4A33-84BF-FA2D015427F7 Q28364187-82EAD97B-265A-4CC1-A0C1-4B7591887F1C Q28367225-247B4A3A-E73A-45B3-9A2E-1FA5DB7BBC43 Q33353691-E42715A7-503F-4A95-BB64-9787DF16770E Q33399797-48A248AA-55F0-4CDA-86AD-BD02A1D58E71 Q33401588-00353628-5361-4DAE-9C06-6E81FC34744D Q33410215-B9E77CDD-9993-46C9-9C05-EE42DFD54C11 Q33465335-8664D731-3ECF-447D-A5CD-900DF5DA55A2 Q33701325-35EA28E9-ADB8-4F83-95F5-B4618F9207C7 Q34497890-1643815A-8B3F-4CA5-B721-7B270D417E9F Q35779318-0C5BA704-457D-4107-9D6C-383CD737C5EE Q36660392-BF6FD151-6119-4E1A-85C4-8FDE27484003 Q37861939-AC72B043-FE27-4978-A42A-CC7FA58B8D3D Q38066198-19DDBB5F-E401-4F35-8A97-D403C174BFC8 Q39095440-99EAD9DD-C961-4AB0-A165-21CC342100B0 Q41475312-CA85DE77-FFB1-4E35-9CF1-F0C89D014E41 Q42068189-FFFDF6DA-A121-4366-B9D7-3939E812521D Q47332682-897EB445-9ABA-4E6B-8C93-528608725422 Q53784556-4239985E-733B-4833-8C37-5CE59DF2B915 Q53824661-1DFB6BFC-53C3-4CA6-ABA1-A41346B6F348 Q54588403-4208A72C-8901-49DD-A859-5A32BE251CDF Q54660979-5FB131ED-2512-4608-948D-66B28F872913 Q54674351-66692447-5F60-40F9-866F-5B3F8B2CCB1A Q55282535-D5142167-C3B9-4478-AF96-64FC04AEA7B9

P2860

Potentially serious side effects of high-dose twice-weekly rifampicin

http://www.wikidata.org/entity/Q28365150

description

1971 nî lūn-bûn

@nan

1971 թուականի Օգոստոսին հրատարակուած գիտական յօդուած

@hyw

1971 թվականի օգոստոսին հրատարակված գիտական հոդված

@hy

1971年の論文

@ja

1971年論文

@yue

1971年論文

@zh-hant

1971年論文

@zh-hk

1971年論文

@zh-mo

1971年論文

@zh-tw

1971年论文

@wuu

name

Potentially serious side effects of high-dose twice-weekly rifampicin

@ast

Potentially serious side effects of high-dose twice-weekly rifampicin

@en

Potentially serious side effects of high-dose twice-weekly rifampicin

@nl

type

label

Potentially serious side effects of high-dose twice-weekly rifampicin

@ast

Potentially serious side effects of high-dose twice-weekly rifampicin

@en

Potentially serious side effects of high-dose twice-weekly rifampicin

@nl

prefLabel

Potentially serious side effects of high-dose twice-weekly rifampicin

@ast

Potentially serious side effects of high-dose twice-weekly rifampicin

@en

Potentially serious side effects of high-dose twice-weekly rifampicin

@nl

P1433

Q28365150-2AD74948-7DEA-41BF-B21E-F832ABBEF724

P1476

Q28365150-257E531D-0648-4A6F-A852-04407CB6CABF

P2093

Q28365150-9D98E253-8E66-48A8-84E3-950DEAB73DC8

Q28365150-A12E3626-988A-4075-A0EE-5D6140A2B7E3

Q28365150-D24675F8-2210-4314-9B38-27E7AD550751

P2860

Q28365150-1C5C150B-E403-4A68-8D4B-EFA44F41C709

Q28365150-9AC3CC36-4A3A-4796-B291-8A0A36F6B5E8

Q28365150-AD9A612E-7DF0-4DDA-ABD3-EF5519A6D2EE

Q28365150-B24610C5-9A5F-43FA-8F40-82A887C797A4

Q28365150-C813356B-34EE-4236-AFFE-7587CB074B7E

Q28365150-F8ACD856-F23E-43DE-BB9C-A06B72EC0462

P304

Q28365150-1F8AC1AD-69F5-4A1B-AB76-003BA4AA4902

P31

Q28365150-9F41004B-1D5B-4728-BB67-6BBB18C5FCD1

P356

Q28365150-0719A117-6CB0-46A2-980C-E2C470121A1D

P407

Q28365150-5A3B508D-41C7-4380-9E30-169CAC2018D9

P433

Q28365150-E023801A-2CDE-4B96-A616-085926BFC3D1

P478

Q28365150-A53181F3-B048-4A23-8800-240C1334BD1C

P577

Q28365150-76D0B2CE-134B-43F8-80D6-28A478E00862

P698

Q28365150-A23D5FF3-B9C3-45E2-ABBF-CE5E9DB3349A

P932

Q28365150-34665A3E-56D8-431A-97C4-92505412F143

P356

P1433

P1476

Potentially serious side effects of high-dose twice-weekly rifampicin

@en

P2093

G Poole

http://www.w3.org/2001/XMLSchema#string

P Stradling

http://www.w3.org/2001/XMLSchema#string

S Worlledge

http://www.w3.org/2001/XMLSchema#string

P2860

Auto-immune hemolytic anemias.

Twice-weekly streptomycin plus isoniazid for tuberculosis.

A four-year follow-up of patients with quiescent pulmonary tuberculosis at the end of a year of chemotherapy with twice-weekly isoniazid plus streptomycin or daily isoniazid plus pas.

Antituberculous activity of rifampin in vitro and in vivo and the concentrations attained in human blood.

Intermittent chemotherapy for tuberculosis in an urban community.

[Jaundice during treatment with rifampicin (12 cases)].

P304

343-7

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1136/BMJ.3.5770.343

http://www.w3.org/2001/XMLSchema#string

P407

P433

5770

http://www.w3.org/2001/XMLSchema#string

P478

3

http://www.w3.org/2001/XMLSchema#string

P577

1971-08-07T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

5314737

http://www.w3.org/2001/XMLSchema#string

P932

1798649

http://www.w3.org/2001/XMLSchema#string